Sunliang C. Cui

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications

Novel Compound Heterozygous Variants in CDH3 Cause Congenital Hypotrichosis with Juvenile Macular Dystrophy: A Case Report with Longitudinal Imaging and Functional Validation.

Novel Compound Heterozygous Variants in CDH3 Cause Congenital Hypotrichosis with Juvenile Macular Dystrophy: A Case Report with Longitudinal Imaging and Functional Validation.

Journal: Case reports in ophthalmology
Published: February 22, 2026

Therapeutic potential of tanshinones in ischaemia-reperfusion injury: Bioactive analogues, pharmacology and mechanisms.

Therapeutic potential of tanshinones in ischaemia-reperfusion injury: Bioactive analogues, pharmacology and mechanisms.

Journal: British journal of pharmacology
Published: January 29, 2026

Discovery of Novel Nonsteroidal SGRMs of Sulfonamide-2-Oxo-Tetrahydroquinoline Derivatives by Carbonyl Migration.

Discovery of Novel Nonsteroidal SGRMs of Sulfonamide-2-Oxo-Tetrahydroquinoline Derivatives by Carbonyl Migration.

Journal: Journal of medicinal chemistry
Published: January 06, 2026

Discovery of γ-Tetrahydrocarboline Derivatives as Plasmodium falciparum Histone Deacetylase Inhibitors for Treatment of Malaria.

Discovery of γ-Tetrahydrocarboline Derivatives as Plasmodium falciparum Histone Deacetylase Inhibitors for Treatment of Malaria.

Journal: Journal of medicinal chemistry
Published: January 04, 2026

Bridged scaffold editing of carbocycles and heterocycles.

Bridged scaffold editing of carbocycles and heterocycles.

Journal: Nature communications
Published: December 03, 2025

Discovery of 2-Ethynylisoborneol as a Highly Potent Anti-seizure Agent.

Discovery of 2-Ethynylisoborneol as a Highly Potent Anti-seizure Agent.

Journal: Journal of medicinal chemistry
Published: June 23, 2025

Research Advances in the Structural Characterization and Biological Activity Assessment of Neocryptotanshinone.

Research Advances in the Structural Characterization and Biological Activity Assessment of Neocryptotanshinone.

Journal: Current medicinal chemistry
Published: May 29, 2025

Asymmetric Formal Synthesis of (-)-Paroxetine.

Asymmetric Formal Synthesis of (-)-Paroxetine.

Journal: Organic letters
Published: May 19, 2025

Peripheral Evolution of Tanshinone IIA and Cryptotanshinone for Discovery of a Potent and Specific NLRP3 Inflammasome Inhibitor.

Peripheral Evolution of Tanshinone IIA and Cryptotanshinone for Discovery of a Potent and Specific NLRP3 Inflammasome Inhibitor.

Journal: Journal of medicinal chemistry
Published: January 23, 2025

Correction: FragGen: towards 3D geometry reliable fragment-based molecular generation.

Correction: FragGen: towards 3D geometry reliable fragment-based molecular generation.

Journal: Chemical science
Published: December 13, 2024

Discovery of naphthoquinone-furo-piperidone derivatives as dual targeting agents of STAT3 and NQO1 for the treatment of breast cancer.

Discovery of naphthoquinone-furo-piperidone derivatives as dual targeting agents of STAT3 and NQO1 for the treatment of breast cancer.

Journal: European journal of medicinal chemistry
Published: December 01, 2024

Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer.

Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer.

Journal: Journal of medicinal chemistry
Published: September 03, 2024
Showing 1-12 of 90

Last Updated: 09/26/2026